Jefferies Q2 profit

Jefferies Quarterly Profit More Than Doubles on Dealmaking, Equities Strength

Jefferies reported Q2 profit doubling driven by M&A advisory fees, including advising on Sun Pharma's $11.75B acquisition of Organon and Kelonia's sale to Eli Lilly.